MODINE MANUFACTURING CO financials

  1. Home
  2. Financials
  3. MOD
MOD CIK 0000067347

Source: EDGAR filings · Built 2026-06-02T03:34:49Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Free Cash Flow 104.70M 128.70M 126.40M 56.30M -29.40M 116.50M
EBITDA 422.10M 361.20M 296.80M 204.90M 174.00M -29.10M
Working Capital 687.20M 420.20M 348.20M 339.30M 263.10M 175.60M
Net Debt 508.40M 379.40M 451.10M 349.00M 389.90M 356.90M
Gross Margin 22.98% 24.92% 21.83% 16.95% 15.09% 16.22%
Operating Margin 10.76% 10.97% 10.00% 6.55% 5.81% -5.40%
Net Margin 3.82% 7.12% 6.71% 6.66% 4.16% -11.65%
Return on Equity (ROE) 10.17% 20.22% 21.60% 25.83% 18.90% -60.42%
Return on Assets (ROA) 4.54% 9.60% 8.72% 9.78% 5.97% -16.50%
Current Ratio 1.94× 1.78× 1.64× 1.67× 1.53× 1.37×
Debt-to-Equity 0.49× 0.50× 0.68× 0.70× 0.97× 1.13×
Effective Tax Rate 33.89% 26.97% 23.86% -22.59% 14.98% -75.61%
Cash Conversion Ratio 2.05× 1.16× 1.33× 0.70× 0.14× -0.71×
Accruals Ratio -0.05× -0.02× -0.03× 0.03× 0.05× -0.28×
SBC % of Revenue 0.69% 1.02% 0.45% 0.29% 0.28% 0.35%
CapEx Coverage 1.73× 2.52× 2.43× 2.10× 0.28× 4.50×
Free Cash Flow Per Share $1.95 $2.39 $2.37 $1.07 $-0.56 $2.27

Valuation Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
P/E Trailing (Diluted) 95.89× 22.44× 31.42× 7.95× 5.56× —
P/FCF 111.36× 32.14× 40.22× 21.62× — 6.50×
FCF Yield 0.90% 3.11% 2.49% 4.63% — 15.38%
EV / EBITDA 30.47× 13.06× 19.51× 7.94× 5.08× —
P/S 3.88× 1.68× 2.22× 0.56× 0.24× 0.44×
P/B 10.34× 4.76× 7.14× 2.15× 1.10× 2.30×

Income Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 3.18B 2.58B 2.41B 2.30B 2.05B 1.81B
Cost of Goods and Services Sold 2.45B 1.94B 1.88B 1.91B 1.74B 1.51B
Gross Profit 731.10M 643.80M 525.60M 389.40M 309.30M 293.40M
Research and Development Expense 29.30M 34.90M 42.00M 44.00M 50.30M 46.30M
Selling, General and Administrative Expense 360.10M 332.10M 273.90M 234.00M 215.10M 210.90M
Operating Income (Loss) 342.40M 283.50M 240.70M 150.40M 119.20M -97.70M
Income Tax Expense (Benefit) 63.20M 68.50M 51.20M -28.30M 15.20M 90.20M
Net Income (Loss) Attributable to Parent 121.50M 184.00M 161.50M 153.10M 85.20M -210.70M
Earnings Per Share, Basic $2.30 $3.50 $3.08 $2.93 $1.64 $-4.11
Weighted Average Number of Shares Outstanding, Basic 52.80M 52.60M 52.40M 52.30M 52.00M 51.30M
Earnings Per Share, Diluted $2.26 $3.42 $3.03 $2.90 $1.62 $-4.11
Weighted Average Number of Shares Outstanding, Diluted 53.80M 53.90M 53.40M 52.80M 52.50M 51.30M

Balance Sheet

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Cash and Cash Equivalents, at Carrying Value 73.50M 71.60M 60.10M 67.10M 45.20M 37.80M
Assets, Current 1.42B 961.20M 894.00M 846.40M 757.60M 644.80M
Assets 2.67B 1.92B 1.85B 1.57B 1.43B 1.28B
Liabilities, Current 728.90M 541.00M 545.80M 507.10M 494.50M 469.20M
Liabilities 1.47B 999.40M 1.10B 966.30M 968.90M 920.60M
Stockholders' Equity Attributable to Parent 1.19B 910.20M 747.60M 592.80M 450.70M 348.70M

Cash Flow Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Net Cash Provided by (Used in) Operating Activities 248.70M 213.30M 214.60M 107.50M 11.50M 149.80M
Payments to Acquire Property, Plant, and Equipment 143.30M 84.00M 87.70M 50.70M 40.30M 32.70M
Net Cash Provided by (Used in) Investing Activities -321.30M -86.60M -283.40M -50.40M -51.00M -31.30M
Payments for Repurchase of Common Stock 7.00M 30.90M 17.70M 9.00M 0 0
Net Cash Provided by (Used in) Financing Activities 73.10M -113.60M 62.70M -33.30M 39.20M -145.10M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (MOD CIK 0000067347), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

CLVT

CLARIVATE PLC

LNTH

LANTHEUS HOLDINGS, INC.

TBPH

THERAVANCE BIOPHARMA, INC.